| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
| HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
| TRIM26BP |
|
tripartite motif containing 26B, pseudogene
|
|
|
0.861 |
0.269 |
| HLA-L |
|
major histocompatibility complex, class I, L (pseudogene)
|
|
|
0.861 |
0.269 |
| RPL18P11 |
|
ribosomal protein L18 pseudogene 11
|
|
|
0.931 |
0.077 |
| HORMAD2-AS1 |
|
HORMAD2 and MTMR3 antisense RNA 1
|
|
|
0.839 |
0.308 |
| HNRNPA1P1 |
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 1
|
|
|
0.931 |
0.154 |
| MEI4 |
A8MW99
|
meiotic double-stranded break formation protein 4
|
|
|
1.000 |
0.077 |
| BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
| CHEK2 |
O96017
|
checkpoint kinase 2
|
Kinase
|
1.2E-24 |
0.460 |
0.808 |
| NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
| C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
| TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
| CFB |
P00751
|
complement factor B
|
|
4.7E-16 |
0.532 |
0.769 |
| STAMBPL1 |
Q96FJ0
|
STAM binding protein like 1
|
Enzyme
|
1.2E-14 |
0.729 |
0.462 |
| MSH5 |
O43196
|
mutS homolog 5
|
Nucleic acid binding
|
3.2E-11 |
0.641 |
0.692 |
| RAD52 |
P43351
|
RAD52 homolog, DNA repair protein
|
Nucleic acid binding
|
7.1E-11 |
0.610 |
0.654 |
| PGBD1 |
Q96JS3
|
piggyBac transposable element derived 1
|
|
4.7E-10 |
0.821 |
0.269 |
| ABCF1 |
Q8NE71
|
ATP binding cassette subfamily F member 1
|
Enzyme
|
1.3E-09 |
0.674 |
0.538 |